ENTPD2 and neoplasm: Further, in order to support the importance of ICD during the tumor immunotherapy, the anti-CRT antibody and ecto-ATPase CD39 were intraperitoneally (i.p.)injected every 3 days to block CRT and metabolize ATP starting on day −3.